So Much for Leaving Abortion Up to the States
Louisiana is suing the FDA to block the nationwide mailing of mifepristone, a common abortion medication. The state argues that the Comstock Act prohibits mailing abortion-related materials, potentially overriding state-level protections for telemedicine abortion access.
Why it matters
This case challenges the FDA's regulatory authority and could lead to a nationwide restriction on medication abortion, regardless of individual state laws.
Louisiana’s case against the FDA is not just about one drug.
The article frames the lawsuit as an overreach by anti-abortion activists and highlights the potential negative impact on abortion access.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in